For most patients, pharmacological intervention (usually a β-blocker or sotalol) is required to reduce the symptoms caused by arrhythmias. However, the efficacy of antiarrhythmic agents has not ...

The sodium channel blocker market is expanding due to the increasing prevalence of neuropathic pain and the demand for more selective treatments like Nav1.7 and Nav1.8 inhibitors. Advances in drug ...

Class I antiarrhythmic drugs possess this characteristic as well. The importance of this is not clear in clinical medicine in regards to beta-blockers. Perhaps this is partially an explanation for ...

Among the most prescribed drugs for this purpose are beta blockers, calcium channel blockers, and a variety of antiarrhythmic ...

Antiarrhythmic drugs act on the electrical ... 2020;4a-b] Concomitant use with beta-blockers and quinidine is also contraindicated. Class IV antiarrhythmics may cause bradycardia, AV block ...